Myelomgruppen

Organisation: forskargrupp

Fler filtreringsmöjligheter
  1. 2020
  2. Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels

    Jennifer L.J. Heaney, Alex Richter, Stella Bowcock, Guy Pratt, J. Anthony Child, Graham Jackson, Gareth Morgan, Ingemar Turesson & Mark T. Drayson, 2020 apr, I : Haematologica. 105, 4, s. E169-E171

    Forskningsoutput: TidskriftsbidragLetter

  3. NCF1-339 polymorphism is associated with altered formation of neutrophil extracellular traps, high serum interferon activity and antiphospholipid syndrome in systemic lupus erythematosus

    Petrus Linge, Sabine Arve, Lina M. Olsson, Dag Leonard, Christopher Sjöwall, Martina Frodlund, Iva Gunnarsson, Elisabet Svenungsson, Helena Tydén, Andreas Jönsen, Robin Kahn, Åsa Johansson, Lars Rönnblom, Rikard Holmdahl & Anders Bengtsson, 2020 feb, I : Annals of the Rheumatic Diseases. 79, 2, s. 254-261 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. Genetic predisposition for multiple myeloma

    Maroulio Pertesi, Molly Went, Markus Hansson, Kari Hemminki, Richard S. Houlston & Björn Nilsson, 2020 jan 8, I : Leukemia.

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  5. Outcome and characteristics of non-measurable myeloma: A cohort study with population-based data from the Swedish Myeloma Registry

    Göran Wålinder, Jan Samuelsson, Per Näsman, Markus Hansson, Gunnar Juliusson, Karin Forsberg, Ronald Svensson, Olle Linder, Kristina Carlson, Sigurdur Y. Kristinsson, Ulf Henrik Mellqvist, Cecilie Hveding Blimark, Ingemar Turesson & Hareth Nahi, 2020, I : European Journal of Haematology. 104, 5, s. 376-382 7 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. Search for multiple myeloma risk factors using Mendelian randomization

    Molly Went, Alex J. Cornish, Philip J. Law, Ben Kinnersley, Mark van Duin, Niels Weinhold, Asta Försti, Markus Hansson, Pieter Sonneveld, Hartmut Goldschmidt, Gareth J. Morgan, Kari Hemminki, Björn Nilsson, Martin Kaiser & Richard S. Houlston, 2020, I : Blood Advances. 4, 10, s. 2172-2179 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. 2019
  8. All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma

    Meletios A. Dimopoulos, Sebastian Grosicki, Wiesław W. Jędrzejczak, Hareth Nahi, Astrid Gruber, Markus Hansson, Neeraj Gupta, Catriona Byrne, Richard Labotka, Zhaoyang Teng, Huyuan Yang, Norbert Grzasko & Shaji Kumar, 2019, I : European Journal of Cancer. 106, s. 89-98 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. Aspects of Phagocyte Function in Multiple Myeloma

    Stina Wichert, 2019, Lund: Lund University: Faculty of Medicine. 97 s.

    Forskningsoutput: AvhandlingDoktorsavhandling (sammanläggning)

  10. Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genes

    Molly Went, Ben Kinnersley, Amit Sud, David C Johnson, Niels Weinhold, Asta Försti, Mark van Duin, Giulia Orlando, Jonathan S Mitchell, Rowan Kuiper, Brian A. Walker, Walter M. Gregory, Per Hoffmann, Graham H. Jackson, Markus M Nöthen, Miguel Inacio da Silva Filho, Hauke Thomsen, Annemiek Broyl, Faith E. Davies, Unnur Thorsteinsdottir & 9 andra, Markus Hansson, Martin Kaiser, Pieter Sonneveld, Hartmut Goldschmidt, Kari Stefansson, Kari Hemminki, Björn Nilsson, Gareth J. Morgan & Richard S. Houlston, 2019, I : Human Genomics. 13, 1, 37.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. 2018
  12. Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology

    Molly Went, Amit Sud, Helen Speedy, Nicola J. Sunter, Asta Försti, Philip J. Law, David C. Johnson, Fabio Mirabella, Amy Holroyd, Ni Li, Giulia Orlando, Niels Weinhold, Mark van Duin, Bowang Chen, Jonathan S. Mitchell, Larry Mansouri, Gunnar Juliusson, Karin E. Smedby, Sandrine Jayne, Aneela Majid & 35 andra, Claire Dearden, David J. Allsup, James R. Bailey, Guy Pratt, Chris Pepper, Chris Fegan, Richard Rosenquist, Rowan Kuiper, Owen W. Stephens, Uta Bertsch, Peter Broderick, Hermann Einsele, Walter M. Gregory, Jens Hillengass, Per Hoffmann, Graham H. Jackson, Karl Heinz Jöckel, Jolanta Nickel, Markus M. Nöthen, Miguel Inacio da Silva Filho, Hauke Thomsen, Brian A. Walker, Annemiek Broyl, Faith E. Davies, Markus Hansson, Hartmut Goldschmidt, Martin J.S. Dyer, Martin Kaiser, Pieter Sonneveld, Gareth J. Morgan, Kari Hemminki, Björn Nilsson, Daniel Catovsky, James M. Allan & Richard S. Houlston, 2018 dec 21, I : Blood Cancer Journal. 9, 1, 1.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression

    Mina Ali, Ram Ajore, Anna Karin Wihlborg, Abhishek Niroula, Bhairavi Swaminathan, Ellinor Johnsson, Owen W. Stephens, Gareth Morgan, Tobias Meissner, Ingemar Turesson, Hartmut Goldschmidt, Ulf Henrik Mellqvist, Urban Gullberg, Markus Hansson, Kari Hemminki, Hareth Nahi, Anders Waage, Niels Weinhold & Björn Nilsson, 2018 dec 1, I : Nature Communications. 9, 1, 1649.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. Bone marrow eosinophils in plasma cell disorders

    Stina Wichert, Åsa Pettersson, Thomas Hellmark, Åsa Johansson & Markus Hansson, 2018, I : Experimental Hematology. 66, s. 27-31.e5

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

    Molly Went, Asta Försti, Kari Hemminki, Britt-Marie Halvarsson, Mina Ali, Urban Gullberg, Ellinor Johnsson, Anna-Karin Wihlborg, Markus Hansson, Björn Nilsson, Richard S Houlston & The PRACTICAL Consortium The PRACTICAL Consortium, 2018, I : Nature Communications. 9, 1, 3707.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. 2017
  17. Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone: A pooled analysis

    Philippe Moreau, Meletios A. Dimopoulos, Paul G Richardson, David S. Siegel, Michele Cavo, Paolo Corradini, Katja C. Weisel, Michel Delforge, Peter O'Gorman, Kevin Song, Christine Chen, Nizar Bahlis, Albert Oriol, Markus Hansson, Martin Kaiser, Pekka Anttila, Reinier Raymakers, Cristina Joao, Gordon Cook, Lars Sternas & 7 andra, Tsvetan Biyukov, Ana Slaughter, Kevin Hong, Jennifer Herring, Xin Yu, Mohamed H. Zaki & Jesus San Miguel, 2017 sep 1, I : European Journal of Haematology. 99, 3, s. 199-206 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. A single nucleotide polymorphism in the NCF1 gene leading to reduced oxidative burst is associated with systemic lupus erythematosus

    Lina M. Olsson, Åsa C. Johansson, Birgitta Gullstrand, Andreas Jönsen, Saedis Saevarsdottir, Lars Rönnblom, Dag Leonard, Jonas Wetterö, Christopher Sjöwall, Elisabet Svenungsson, Iva Gunnarsson, Anders A. Bengtsson & Rikard Holmdahl, 2017 sep 1, I : Annals of the Rheumatic Diseases. 76, 9, s. 1607-1613 7 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. Direct evidence for a polygenic etiology in familial multiple myeloma

    Britt-Marie Halvarsson, Anna-Karin Wihlborg, Mina Ali, Konstantinos Lemonakis, Ellinor Johnsson, Abhishek Niroula, Carrie Cibulskis, Niels Weinhold, Asta Försti, Evren Alici, Christian Langer, Michael Pfreundschuh, Hartmut Goldschmidt, Ulf-Henrik Mellqvist, Ingemar Turesson, Anders Waage, Kari Hemminki, Todd Golub, Hareth Nahi, Urban Gullberg & 2 andra, Markus Hansson & Björn Nilsson, 2017 apr 11, I : Blood Advances. 1, 10, s. 619-623

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myeloma

    Stina Wichert, Gunnar Juliusson, Åsa Johansson, Elisabeth Sonesson, Ingrid Teige, Anna Teige Wickenberg, Björn Frendeus, Magnus Korsgren & Markus Hansson, 2017 feb 1, I : PLoS ONE. 12, 2, e0171205.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. Identification of sequence variants influencing immunoglobulin levels

    Stefan Jonsson, Gardar Sveinbjornsson, Aitzkoa Lopez de Lapuente Portilla, Bhairavi Swaminathan, Rosina Plomp, Gillian Dekkers, Ram Ajore, Mina Ali, Arthur E H Bentlage, Evelina Elmér, Gudmundur Ingi Eyjolfsson, Sigurjon A. Gudjonsson, Urban Gullberg, Arnaldur Gylfason, Bjarni V. Halldorsson, Markus Hansson, Hilma Holm, Åsa Johansson, Ellinor Johnsson, Aslaug Jonasdottir & 18 andra, Bjorn R Ludviksson, Asmundur Oddsson, Isleifur Olafsson, Sigurgeir Olafsson, Olof Sigurdardottir, Asgeir Sigurdsson, Lilja Stefansdottir, Gisli Masson, Patrick Sulem, Manfred Wuhrer, Anna-Karin Wihlborg, Gudmar Thorleifsson, Daniel F. Gudbjartsson, Unnur Thorsteinsdottir, Gestur Vidarsson, Ingileif Jonsdottir, Björn Nilsson & Kari Stefansson, 2017, I : Nature Genetics. 49, 8, s. 1182-1191

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study

    M. A. Dimopoulos, E Kastritis, E Terpos, H Nahi, H. Goldschmidt, J Hillengass, X Leleu, Meral Beksac, M Alsina, Albert Oriol, M. Cavo, E. M. Ocio, M. V. Mateos, E K O'Donnell, R Vij, Henk M Lokhorst, Niels W C J van de Donk, J. Cam-min, Torrance Mark, I Turesson & 21 andra, Markus Hansson, S. Jagannath, M Delforge, Charalampia Kyriakou, P Hari, U. H. Mellqvist, S Z Usmani, D Dytfeld, Ashraf Z Badros, P R Otero, C Shustik, D Waller, W-J Chng, Shoichi Ozaki, Javier de la Rubia, H S Eom, L Rosinol, J. J. Lahuerta, A Sureda, J. S. Kim & B. G. M. Durie, 2017, I : Leukemia. 31, s. 2443-2448

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. 2016
  24. Oral Ixazomib, lenalidomide, and dexamethasone for multiple myeloma

    Philippe Moreau, T. Masszi, N. Grzasko, N. J. Bahlis, Markus Hansson, L. Pour, I. Sandhu, P. Ganly, B. W. Baker, S. R. Jackson, A. M. Stoppa, D. R. Simpson, P. Gimsing, A. Palumbo, L. Garderet, M. Cavo, S. Kumar, C. Touzeau, F. K. Buadi, J. P. Laubach & 21 andra, D. T. Berg, J. Lin, A. Di Bacco, A. M. Hui, H. Van De Velde, P. G. Richardson, Eric Kupperman, Allison Berger, Larry Dick, Mark Williamson, Dharminder Chauhan, Kenneth Anderson, Dixie Lee Esseltine, Liviu Niculescu, Stacey Taraskiewicz, Jeff Stecklair, Sagar Lonial, Vincent Rajkumar, Jésus San Miquel, Hermann Einsele & Robert Orlowski, 2016 apr 28, I : New England Journal of Medicine. 374, 17, s. 1621-1634 14 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma.

    Sonja Zweegman, Bronno van der Holt, Ulf-Henrik Mellqvist, Morten Salomo, Gerard M J Bos, Mark-David Levin, Heleen Visser-Wisselaar, Markus Hansson, Annette W G van der Velden, Wendy Deenik, Astrid Gruber, Juleon L L M Coenen, Torben Plesner, Saskia K Klein, Bea C Tanis, Damian L Szatkowski, Rolf E Brouwer, Matthijs Westerman, M Rineke B L Leys, Harm A M Sinnige & 8 andra, Einar Haukås, Klaas G van der Hem, Marc F Durian, E Vera J M Mattijssen, Niels W C J van de Donk, Marian J P L Stevens-Kroef, Pieter Sonneveld & Anders Waage, 2016, I : Blood. 127, 9, s. 1109-1116

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. Phagocyte Function Decreases after High-Dose Treatment with Melphalan and Autologous Stem Cell Transplantation in Patients with Multiple Myeloma.

    Stina Wichert, Åsa Pettersson, Thomas Hellmark, Åsa Johansson & Markus Hansson, 2016, I : Experimental Hematology. 44, 5, s. 342–351

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. 2015
  28. Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo.

    Ali Roghanian, Ingrid Teige, Linda Mårtensson, Kerry L Cox, Mathilda Kovacek, Anne Ljungars, Jenny Mattson, Annika Sundberg, Andrew T Vaughan, Vallari Shah, Neil R Smyth, Bhavwanti Sheth, H T Claude Chan, Zhan-Chun Li, Emily L Williams, Giusi Manfredi, Robert J Oldham, C Ian Mockridge, Sonya A James, Lekh N Dahal & 12 andra, Khiyam Hussain, Björn Nilsson, J Sjef Verbeek, Gunnar Juliusson, Markus Hansson, Mats Jerkeman, Peter W M Johnson, Andrew Davies, Stephen A Beers, Martin J Glennie, Björn Frendéus & Mark S Cragg, 2015, I : Cancer Cell. 27, 4, s. 473-488

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. A phase 1 dose-escalation study of antibody BI-505 in relapsed/refractory multiple myeloma.

    Markus Hansson, Peter Gimsing, Ashraf Z Badros, Titti Martinsson Niskanen, Hareth Nahi, Fritz Offner, Morten Salomo, Elisabeth Sonesson, Morten Mau-Sorensen, Yvonne Stenberg, Annika Sundberg, Ingrid Teige, Jan van Droogenbroeck, Stina Wichert, Maurizio Zangari, Bjorn Frendeus, Magnus Korsgren, Martine Poelman & Guido Tricot, 2015, I : Clinical Cancer Research. 21, 12, s. 2730-2736

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma.

    Henk M Lokhorst, Torben Plesner, Jacob P Laubach, Hareth Nahi, Peter Gimsing, Markus Hansson, Monique C Minnema, Ulrik Lassen, Jakub Krejcik, Antonio Palumbo, Niels W C J van de Donk, Tahamtan Ahmadi, Imran Khan, Clarissa M Uhlar, Jianping Wang, A Kate Sasser, Nedjad Losic, Steen Lisby, Linda Basse, Nikolai Brun & 1 andra, Paul G Richardson, 2015, I : New England Journal of Medicine. 373, 13, s. 1207-1219

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  31. Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.

    Bhairavi Swaminathan, Guðmar Thorleifsson, Magnus Jöud, Mina Ali, Ellinor Johnsson, Ram Ajore, Patrick Sulem, Britt-Marie Halvarsson, Guðmundur Eyjolfsson, Vilhelmina Haraldsdottir, Christina Hultman, Erik Ingelsson, Sigurður Y Kristinsson, Anna K Kähler, Stig Lenhoff, Gisli Masson, Ulf-Henrik Mellqvist, Robert Månsson, Sven Nelander, Isleifur Olafsson & 14 andra, Olof Sigurðardottir, Hlif Steingrimsdóttir, Annette Vangsted, Ulla Vogel, Anders Waage, Hareth Nahi, Daniel F Gudbjartsson, Thorunn Rafnar, Ingemar Turesson, Urban Gullberg, Kári Stefánsson, Markus Hansson, Unnur Thorsteinsdóttir & Björn Nilsson, 2015, I : Nature Communications. 6, s. 1-8 7213.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. 2014
  33. Robust isolation of malignant plasma cells in multiple myeloma.

    Ildiko Frigyesi, Jörgen Adolfsson, Mina Ali, Mikael Kronborg Christophersen, Ellinor Johnsson, Ingemar Turesson, Urban Gullberg, Markus Hansson & Björn Nilsson, 2014, I : Blood. 123, 9, s. 1336-1340

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  34. 2013
  35. A human icam-1 antibody isolated by a function-first approach has potent macrophage-dependent antimyeloma activity in vivo.

    Niina Veitonmäki, Markus Hansson, Fenghuang Zhan, Annika Sundberg, Tobias Löfstedt, Anne Ljungars, Zhan-Chun Li, Titti Martinsson-Niskanen, Ming Zeng, Ye Yang, Lena Danielsson, Mathilda Kovacek, Andrea Lundqvist, Linda Mårtensson, Ingrid Teige, Guido Tricot & Björn Frendéus, 2013, I : Cancer Cell. 23, 4, s. 502-515

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift